Home > Research > Publications & Outputs > Therapeutic Potential of Baicalein in Alzheimer...

Electronic data

  • manuscript_clean_copy

    Rights statement: The final publication is available at Springer via http://dx.doi.org/10.1007/s40263-017-0451-y

    Accepted author manuscript, 689 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Research output: Contribution to journalJournal article

Published
Close
<mark>Journal publication date</mark>08/2017
<mark>Journal</mark>CNS Drugs
Issue number8
Volume31
Number of pages14
Pages (from-to)639-652
Publication statusPublished
Early online date20/06/17
Original languageEnglish

Abstract

Alzheimer's disease and Parkinson's disease are the two most common, progressive central neurodegenerative diseases affecting the population over the age of 60 years. Apart from treatments that temporarily improve symptoms, there is no medicine currently available to inhibit or reverse the progression of Alzheimer's disease and Parkinson's disease. In traditional Chinese medicine, the root of Scutellaria baicalensis Georgi is a classic compatible component in the decoction of herbal medicine used for treating central nervous system diseases. Modern pharmacokinetic studies have confirmed that baicalein (5,6,7-trihydroxyflavone) is a major bioactive flavone constituent root of S. baicalensis Georgi. Studies showed that baicalein possesses a range of key pharmacological properties, such as reducing oxidative stress, anti-inflammatory properties, inhibiting aggregation of diseasespecific amyloid proteins, inhibiting excitotoxicity, stimulating neurogenesis and differentiation action, and antiapoptosis effects. Based on these properties, baicalein shows therapeutic potential for Alzheimer's disease and Parkinson's disease. In this review, we summarize the pharmacological protective actions of baicalein that make it suitable for the treatment of Alzheimer's disease and Parkinson's disease, and discuss the potential mechanisms underlying the effects.

Bibliographic note

The final publication is available at Springer via http://dx.doi.org/10.1007/s40263-017-0451-y